# Promoting Medications for Alcohol Use Disorder on the General Medicine Service

> **NCT04287790** · — · TERMINATED · sponsor: **Yale University** · enrollment: 67 (actual)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **BEHAVIORAL:** audit and feedback, educational meetings, and academic detailing to promote medication receipt
- **DRUG:** Acamprosate, naltrexone, or disulfiram

## Key facts

- **NCT ID:** NCT04287790
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-01
- **Primary completion:** 2020-06-01
- **Final completion:** 2021-02-01
- **Target enrollment:** 67 (ACTUAL)
- **Why stopped:** COVID-19 disrupted recruitment
- **Last updated:** 2022-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04287790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04287790, "Promoting Medications for Alcohol Use Disorder on the General Medicine Service". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04287790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*